A new report on Crestor is raising safety concerns AGAIN
July 2005
A new report on Crestor is raising safety concerns AGAIN.
This analysis suggests a trend towards more cases of severe myopathy and a higher rate of proteinuria with Crestor.
Health Canada looked at this data previously and decided to leave Crestor on the market...with conservative dosing.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive